MENU
LENZ
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
LENZ Therapeutics (LENZ) Ownership - Who owns LENZ Therapeutics?
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products... Show more
Profile
Industry
N/A
Address
445 Marine View Avenue
Phone
+1 858 925-7000
Employees
N/A
Web
https://www.lenz-tx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
622.9M
P/E Ratio
N/A
Total Cash
217.11M
Projected Growth
N/A
Total Debt
1.58M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
7.89
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
LENZ
Capitalization
623M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
217M
Total Cash/Share
7.89
Total Debt
1.58M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
215M
P/B Ratio
2.89
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
28.63
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
1.69B
Shares Outstanding - Current
27.5M
Total Liabilities
8.73M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-21.545
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
445 Marine View Avenue
Phone
+1 858 925-7000
Employees
N/A
Web
https://www.lenz-tx.com